The combination of shLNCAROD and shSRSF3 yielded a stronger inhibitory effect on HCC proliferation than their individual knockdown, whereas a stronger proliferation-promoting effect was observed for the combined overexpression of LNCAROD and SRSF3 (Figure S7A-B). Here, LNCAROD is linked to hepatocellular carcinoma.